Please use this identifier to cite or link to this item:
https://mnclhd.intersearch.com.au/mnclhdjspui/handle/123456789/387| Title: | A successful re-trial after clozapine myopericarditis |
| Authors: | Sarathy, K.;Alexopoulos, C. |
| MNCLHD Author: | Sarathy, Kiran Alexopoulos, Chris |
| Issue Date: | Jun-2017 |
| Citation: | Journal of the Royal College of Physicians of Edinburgh. 2017 Jun;47(2):146-147. doi: 10.4997/JRCPE.2017.209. |
| Abstract: | Clozapine-induced myopericarditis is a well-described adverse drug reaction. Clozapine is also the most efficacious agent in refractory schizophrenia. We report a case of a patient who was successfully re-trialled on clozapine two years after developing myopericarditis, after which multiple lines of alternative treatment failed. We propose a protocol for safely attempting a re-trial of clozapine in such cases. |
| URI: | https://mnclhd.intersearch.com.au/mnclhdjspui/handle/123456789/387 |
| Keywords: | Clozapine;Schizophrenia;Schizophrenia, Treatment-Resistant;Drug-Related Side Effects and Adverse Reactions;Myocarditis |
| Appears in Collections: | Mental Health |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.